UNSPSC 85532038: Supplement left greater saphenous vein with synthetic substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left greater saphenous vein with synthetic substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 06UQ4JZ

UNSPSC 85532038 Supplement left greater saphenous vein with synthetic substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity under state and local procurement. The code's nominal scope describes a specific vascular surgical procedure, but the recent opportunities tagged to this code do not involve vascular surgery, synthetic vein grafts, or endoscopic vascular interventions. Instead, the posted solicitations cover occupational medical surveillance (Washington State Ferries), independent medical evaluations for disability retirement determinations (City of Phoenix), surgical procedure carve-out benefits through Centers of Excellence networks (City of Long Beach), pharmacy benefit management (Collier County), temporary health professional staffing (Santa Clara County Health System), specialty medical services for detained youth (Harris County), and general RFI activity. None of these solicitations involve implantable vascular devices or the specific procedure named in the code.

The mismatch between the code's clinical description and the actual scope of work in recent state and local opportunities suggests either a classification error in the posting systems or that this code is not actively used for procurement activity in the state and local market. State and local procurement offices do not typically solicit vascular implant procedures as standalone commodities; such services are embedded within hospital contracts, physician networks, or bundled surgical programs. If your firm works in vascular device supply or implant distribution, this code does not currently reflect actionable procurement signals.